Evidence map›Paper›PMID 39407524›Full record

ArticleMolecules (Basel, Switzerland)2024

Ascorbic Acid and Graphene Oxide Exposure in the Model Organism

Barbara Flasz, Monika Tarnawska, Andrzej Kędziorski, Łukasz Napora-Rutkowski, Joanna Szczygieł, Łukasz Gajda, Natalia Nowak, Maria Augustyniak

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Barbara FlaszInstitute of Biology, Biotechnology and Environmental Protection, University of Silesia in Katowice, 40-032 Katowice, Poland.ORCID 0000-0002-1405-446X
Monika TarnawskaInstitute of Biology, Biotechnology and Environmental Protection, University of Silesia in Katowice, 40-032 Katowice, Poland.
Andrzej KędziorskiInstitute of Biology, Biotechnology and Environmental Protection, University of Silesia in Katowice, 40-032 Katowice, Poland.ORCID 0000-0003-0598-9981
Łukasz Napora-RutkowskiPolish Academy of Sciences, Institute of Ichthyobiology and Aquaculture in Gołysz, 43-520 Zaborze, Poland.
Joanna SzczygiełPolish Academy of Sciences, Institute of Ichthyobiology and Aquaculture in Gołysz, 43-520 Zaborze, Poland.
Łukasz GajdaInstitute of Biology, Biotechnology and Environmental Protection, University of Silesia in Katowice, 40-032 Katowice, Poland.ORCID 0000-0003-4710-650X
Natalia NowakInstitute of Biology, Biotechnology and Environmental Protection, University of Silesia in Katowice, 40-032 Katowice, Poland.
Maria AugustyniakInstitute of Biology, Biotechnology and Environmental Protection, University of Silesia in Katowice, 40-032 Katowice, Poland.ORCID 0000-0003-1960-1669

Funding

National Science Center UMO-2019/33/N/NZ8/00345The Research Excellence Initiative of the University of Silesia in Katowice no number
6 · The paper itself

Abstract

The use of nanoparticles in the industry carries the risk of their release into the environment. Based on the presumption that the primary graphene oxide (GO) toxicity mechanism is reactive oxygen species production in the cell, the question arises as to whether well-known antioxidants can protect the cell or significantly reduce the effects of GO. This study focused on the possible remedial effect of vitamin C in

Indexed as

Ascorbic AcidGraphiteReproductionVitellogeninsAnimalsAntioxidantsFemaleNanoparticlesAntioxidantsAscorbic Acidgraphene oxideGraphiteVitellogeninsAcheta domesticusascorbic acidgraphene oxidevitellogenin

Identifiers

PMID39407524
PMCPMC11478226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.